Zhao Zhifang, Qin Song, Wang Li, Li Lili, Liu Youde, Deng Lixia, Zou Zhiqiang
Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, Shandong, China.
Center for Ocean Mega-Science, Chinese Academy of Sciences, Qingdao 266071, Shandong, China.
Sheng Wu Gong Cheng Xue Bao. 2021 Jan 25;37(1):301-311. doi: 10.13345/j.cjb.200279.
Chronic hepatitis B (CHB) is a global epidemic disease caused by hepatitis B virus that can lead to hepatic failure, even liver cirrhosis and hepatocellular carcinoma. The occurrence and development of CHB are closely related to the changes in the gut microbiota communities. To explore the relationship between the structure of gut microbiota and liver biochemical indicators, 14 CHB patients (the CHB group) and 11 healthy people (the CN group) were randomly enrolled in this study. Our results demonstrate that CHB caused changes in the gut microbiota communities and biochemical indicators, such as alanine transaminase, total bilirubin and gamma glutamyl transferase. Furthermore, CHB induced imbalance of the gut microbiota. Prevotella, Blautia, Ruminococcus, Eubacterium eligens group, Bacteroides uniformis and Ruminococcus sp. 5_1_39BFAA were associated with the critical biochemical indicators and liver injury, suggesting a new approach to CHB treatment.
慢性乙型肝炎(CHB)是一种由乙型肝炎病毒引起的全球性流行病,可导致肝衰竭,甚至肝硬化和肝细胞癌。CHB的发生和发展与肠道微生物群落的变化密切相关。为了探讨肠道微生物群结构与肝脏生化指标之间的关系,本研究随机纳入了14例CHB患者(CHB组)和11名健康人(CN组)。我们的结果表明,CHB导致肠道微生物群落和生化指标发生变化,如丙氨酸转氨酶、总胆红素和γ-谷氨酰转移酶。此外,CHB诱导肠道微生物群失衡。普雷沃氏菌属、布劳特氏菌属、瘤胃球菌属、 eligens真杆菌群、单形拟杆菌和瘤胃球菌属5_1_39BFAA与关键生化指标和肝损伤相关,提示了一种CHB治疗的新方法。